Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human herpesvirus 6

P Lusso1, R C Gallo

  • 1Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, MD 20892, USA.

Bailliere'S Clinical Haematology
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Human herpesvirus 6 (HHV-6) is a novel pathogen causing infant illness and potentially worsening HIV. Further research is needed to understand its full impact on human diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis.

Bone marrow transplantation·2012
Same author

7q-and loss of a polymorphism for the met oncogene in a patient with myelofibrosis.

Cytotechnology·2012
Same author

Productive infection of HUVEC by HHV-8 is associated with changes compatible with angiogenic transformations.

European journal of histochemistry : EJH·2005
Same author

Chemokine receptors as new molecular targets for antiviral therapy.

The new microbiologica·2005
Same author

Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.

Nature medicine·2001
Same author

Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES.

Nature structural biology·2001
Same journal

Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

Bailliere's clinical haematology·2000
Same journal

Pharmacological therapy.

Bailliere's clinical haematology·2000
Same journal

Prenatal diagnosis and screening of the haemoglobinopathies.

Bailliere's clinical haematology·2000
Same journal

Sickle cell disease: clinical management.

Bailliere's clinical haematology·2000
Same journal

Pathophysiology of sickle cell disease.

Bailliere's clinical haematology·2000
Same journal

Thalassaemia: clinical management.

Bailliere's clinical haematology·2000
See all related articles

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Human herpesvirus 6 (HHV-6) is identified as the first T-lymphotropic human herpesvirus.
  • HHV-6 is recognized as a significant emerging human pathogen.
  • It is the causative agent of exanthem subitum in infants.

Purpose of the Study:

  • To highlight the significance of HHV-6 as a human pathogen.
  • To discuss the potential role of HHV-6 in immunocompromised patients.
  • To explore the suggested acceleration of HIV progression by HHV-6.

Main Methods:

  • Review of clinical and experimental evidence.
  • Analysis of current research on human lymphotropic viruses and immunity.

Main Results:

Related Experiment Videos

  • HHV-6 causes exanthem subitum in infants.
  • HHV-6 may act as an opportunistic agent in immunocompromised individuals.
  • Evidence suggests HHV-6 may accelerate HIV progression.

Conclusions:

  • The full spectrum of diseases associated with HHV-6 is not yet fully understood.
  • Animal models for HHV-6 infection require further investigation.
  • Future research is critical for a comprehensive understanding of HHV-6's role in human diseases.